image
BioLineRx Ltd. BLRX
Healthcare - Biotechnology - NASDAQ - IL
Watchlist
$ 0.4755
4.69 %
$ 39.8 M
Market Cap
-1.03
P/E
BALANCE SHEET
63.9 M ASSETS
-16.31%
Growth Rates
1Year -16.31%
3Years 10.57%
5Years 2.60%
7Years 7.34%
10Years 12.35%
50.7 M LIABILITIES
98.50%
Growth Rates
1Year 98.50%
3Years 26.14%
5Years 27.73%
7Years 44.19%
10Years 19.89%
13.2 M EQUITY
-73.99%
Growth Rates
1Year -73.99%
3Years -15.65%
5Years -20.38%
7Years -12.99%
10Years 1.25%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition BioLineRx Ltd.
image
Current Assets 47.2 M
Cash & Short-Term Investments 43 M
Receivables 708 K
Other Current Assets 3.48 M
Non-Current Assets 16.7 M
Long-Term Investments 0
PP&E 1.89 M
Other Non-Current Assets 14.9 M
Current Liabilities 30.9 M
Accounts Payable 10.9 M
Short-Term Debt 3.67 M
Other Current Liabilities 16.3 M
Non-Current Liabilities 19.8 M
Long-Term Debt 7.92 M
Other Non-Current Liabilities 11.9 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 4.3 10.6 13.0 16.8 5.3 3.4 5.1 2.5 5.5 5.8 8.9 18.3 8.7
Short Term Investments 38.7 40.5 44.1 5.8 22.2 26.7 44.4 33.2 42.1 28.9 9.3 3.1 17.3
Receivables 0.7 0.7 0.1 0.1 0.6 1.3 0.6 0 0.3 0.3 0.4 0 1.0
Inventory 2.0 (41.2) 0 0 0 0 (44.1) 0 (41.9) 36.2 K 0.000001 2 0
Other Current Assets 1.5 0.2 0.1 0.2 0.1 0.5 0.3 0.3 0.2 0.2 0.3 0.2 0.2
Total Current Assets 47.2 52.0 57.4 22.9 28.2 32.0 50.4 36.1 48.2 35.1 18.8 22.2 27.2
PP&E 1.9 2.5 2.3 2.7 3.5 2.2 2.5 2.6 2.9 0.7 0.7 0.8 1.1
Intangible Assets 14.9 21.9 21.7 21.7 21.9 22.0 7.0 0.2 0.2 0.1 0.3 0.3 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 1.0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 56 K 61 K 52 K 58 K 0.2 0.2 1.0 0.8
Other Assets 0 0 0 0 0 0 0 0 0 0 0 1 1
Total Assets 63.9 76.4 81.4 47.3 53.6 56.2 61.0 38.9 51.3 36.2 19.9 24.3 29.3
LIABILITIES
Accounts Payable 10.9 7.0 5.6 5.9 7.8 4.5 5.5 2.6 1.9 1.7 2.3 3.3 3.0
Short Term Debt 3.7 2.4 2.9 3.3 2.9 0.9 93 K 93 K 93 K 0 0 36.7 K (3.4)
Other Current Liabilities 3.4 1.3 1.2 1.4 1.3 1.4 1.1 1.0 1.1 1.3 0.8 3.1 2.0
Total Current Liabilities 30.9 10.7 9.7 10.6 12.0 6.8 6.7 3.7 3.1 2.9 3.0 6.4 6.8
Long Term Debt 7.9 10.4 1.7 4.4 7.6 7.8 0.2 0.2 0.3 0 0 0 28.9 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 11.9 4.5 1.9 10.2 0.7 0.3 1.2 1 K 0.2 1.5 5.3 2.9 21.8 K
Total Liabilities 50.7 25.5 13.3 25.3 20.2 14.9 8.1 3.9 3.7 4.4 8.3 9.3 6.8
EQUITY
Common Stock 31.4 27.1 21.1 9.9 4.7 3.1 2.8 1.5 1.5 1.0 0.7 0.5 0.3
Retained Earnings (390.6) (330.0) (305.0) (278.0) (248.0) (222.5) (199.6) (175.2) (159.4) (140.1) (145.2) (118.9) (96.7)
Other Accumulative Comprehensive Income/Loss 17.0 13.3 11.7 10.9 10.7 10.5 8.9 9.2 9.3 9.4 9.8 9.0 (2.0)
Total Equity 13.2 50.8 68.1 22.0 33.4 41.3 52.9 35.0 47.6 31.8 11.7 15.0 22.5
Total Liabilities and Equity 63.9 76.4 81.4 47.3 53.6 56.2 61.0 38.9 51.3 36.2 19.9 24.3 29.3
SHARES OUTSTANDING
Common Shares Outstanding 64.2 51.6 44.2 16.9 9.8 7.2 6.0 3.7 3.4 2.2 1.5 1.1 0.8 0.8